Page last updated: 2024-08-24

tenofovir and Tuberculosis, Drug-Resistant

tenofovir has been researched along with Tuberculosis, Drug-Resistant in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leufkens, HGM; Mantel-Teeuwisse, AK; Mavhunga, F; Mekonen, TT; Mengistu, A; Rennie, T; Ruswa, N; Sagwa, EL1
Abdelghani, N; Dawood, H; Naidoo, K; Naidu, N; Padayatchi, N; Perumal, R; Singh, N; Yende-Zuma, N1

Other Studies

2 other study(ies) available for tenofovir and Tuberculosis, Drug-Resistant

ArticleYear
Renal function of MDR-TB patients treated with kanamycin regimens or concomitantly with antiretroviral agents.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2017, 12-01, Volume: 21, Issue:12

    Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Female; Follow-Up Studies; Glomerular Filtration Rate; HIV Infections; Humans; Kanamycin; Kaplan-Meier Estimate; Kidney Function Tests; Male; Middle Aged; Namibia; Proportional Hazards Models; Renal Insufficiency; Retrospective Studies; Tenofovir; Tuberculosis, Multidrug-Resistant; Young Adult

2017
Risk of Nephrotoxicity in Patients With Drug-Resistant Tuberculosis Treated With Kanamycin/Capreomycin With or Without Concomitant Use of Tenofovir-Containing Antiretroviral Therapy.
    Journal of acquired immune deficiency syndromes (1999), 2018, 08-15, Volume: 78, Issue:5

    Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Capreomycin; Creatinine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kanamycin; Kidney; Male; Retrospective Studies; Tenofovir; Tuberculosis, Multidrug-Resistant

2018